{"transactions":[{"id":813579,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option","published_at":"2026-04-08T00:00:03.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":128550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 128,550 shares of the Issuer's common stock (66,954 shares of which are underlying incentive stock options and 61,596 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 128,550 shares of the Issuer's common stock (66,954 shares of which are underlying incentive stock options and 61,596 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."}],"balance_after":128550,"derivative":{"exercise_price":0.98,"underlying":"Common Stock","underlying_shares":128550},"source":{"system":"sec-edgar","filing":"0001493152-26-015592","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000149315226015592/ownership.xml","form_type":"4"}},{"id":1092818,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option","published_at":"2025-07-03T20:45:31.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":6619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 2,621 incentive stock options and 3,998 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of 2,621 incentive stock options and 3,998 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."}],"balance_after":6619,"derivative":{"exercise_price":1.27,"underlying":"Common Stock","underlying_shares":6619},"source":{"system":"sec-edgar","filing":"0001641172-25-017831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000164117225017831/ownership.xml","form_type":"4"}},{"id":1171118,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option","published_at":"2025-04-16T21:18:20.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":26477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."}],"balance_after":26477,"derivative":{"exercise_price":0.8448,"underlying":"Common Stock","underlying_shares":26477},"source":{"system":"sec-edgar","filing":"0001641172-25-005108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000164117225005108/ownership.xml","form_type":"4"}},{"id":1587252,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Options","published_at":"2024-03-08T21:28:31.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":190000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024."}],"balance_after":190000,"derivative":{"exercise_price":1.69,"underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001493152-24-009409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000149315224009409/ownership.xml","form_type":"4"}}]}